Skip to main content
Back
finqOS
Search a stock, list or screen
⌘K
Not investment advice
Read full disclaimer
DMAC
———
Overview
Company
Financials
Valuation
News
Ownership
Documents
DMAC: DiaMedica Therapeutics Inc. Stock Analysis | finqOS
DMAC
$8.25
+2.87%
Lists
Call DMAC
DiaMedica Therapeutics
DMAC
Back
Lists
Call DMAC
$8.25
+$0.23 · +2.87%
Closed
Overview
Company
Financials
Valuation
News
Ownership
Documents
Up
27%
in three months and
52%
of the way up its 52-week range.
Call DMAC
Loading chart data...
Signal state